CAMP4 Therapeutics Corporation Common Stock

Shares of CAMP4 Therapeutics Corporation Common Stock (CAMP) are trading at $3.30. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (15475.3%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, CAMP trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Oct 23, 2026.